Responses
Therapeutics
Randomised controlled trial
Treatment with the probiotic VSL#3 as an adjunctive therapy in relapsing mild-to-moderate ulcerative colitis significantly reduces ulcerative colitis disease activity
Compose a Response to This Article
Other responses
No responses have been published for this article.